Drug Discovery

TIPS 3 Results

Principal investigator Prem Pais, MD summarizes the results of TIPS-3, which tested the use of a polypill for primary prevention of cardiovascular disease.

Science News

2020 AHA/ACC Consensus Conference on Professionalism and Ethics
Preclinical Models of Cancer Therapy–Associated Cardiovascular Toxicity
Heart Disease and Stroke Statistics - 2021 Update
Statin Exposure and Risk of Heart Failure After Anthracycline‐ or Trastuzumab‐Based Chemotherapy for Early Breast Cancer: A Propensity Score‒Matched Cohort Study
AHA names top heart disease and stroke research advances of 2020

Journals

Intracranial Bleeding After Percutaneous Coronary Intervention: Time‐Dependent Incidence, Predictors, and Impact on Mortality
Ticagrelor Monotherapy Versus Ticagrelor With Aspirin in Acute Coronary Syndrome Patients With a High Risk of Ischemic Events
Fibrous Caps in Atherosclerosis Form by Notch-Dependent Mechanisms Common to Arterial Media Development
Ankle-Brachial Index for Risk Stratification in Patients With Symptomatic Peripheral Artery Disease With and Without Prior Lower Extremity Revascularization: Observations From the EUCLID Trial
Pitfalls of Pulse Wave Analysis and Oscillometric Blood Pressure Derivatives

Continuing Education

Doctor looking into a microscope

Meet with us for compelling content and renewed connections at AHA Scientific Sessions 2021. In-person Event in Boston, Massachusetts + Virtual Experience, Saturday, November 13-15.

Abstract presentations are a key component of AHA Scientific Sessions. Abstract presenters have the option to present in person in Boston or as a part of the virtual experience.

The incentive to disseminate the latest cardiovascular and stroke science to colleagues around the world has never been greater.

Clinicians and Scientists thrive on collaboration and sharing their study findings. Present your innovative research to a global audience at Scientific Sessions, the world's premier cardiovascular conference.

We know your work is vital to saving lives. Share it with fellow researchers, clinicians, and scientists.

The ATVB Council focuses on arteriosclerosis, thrombosis and vascular biology. The council advances research, addresses prevention, improves diagnosis and treatment, and works actively with other organizations. It shares reliable information through its annual conference, awards and lectures, and in the AHA’s journal, Arteriosclerosis, Thrombosis, and Vascular Biology.


The CLCD Council supports AHA objectives in clinical cardiology, promotes excellent clinical care, and fosters professional development and education for clinical cardiologists. Through council-sponsored symposia, panels, and scientific conferences, members can access and interpret new developments in the field and promote clinical cardiology to professional and lay audiences.


The GPM Council seeks to advance discovery and translation of biological insights from genetics and omics technologies to improve cardiovascular and brain health through better risk prediction, treatment and prevention for patients. Our expertise spans genetics, genomics, genomic medicine, epigenetics, transcriptomics, metabolomics, proteomics, microbiome, bioinformatics, computational science, and population health.


American Heart Association Professional Members

Enjoy instant benefits!

  • Free Online Access to AHA Scientific Journals
  • Affiliate with our 16 Scientific Councils
  • Discounts on Scientific Conference Registration and Online Courses